Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis
Objectives To assess the risk of new-onset or worsening hyperglycaemia, hypertension, weight gain and hyperlipidaemia with systemic corticosteroid therapy (CST) as reported in published randomised control trial (RCT) studies.Data sources Literature search using MEDLINE, EMBASE, Cochrane library, Web...
Saved in:
| Main Authors: | Szilard Nemes, Veronica Phillips, Spoorthy Kulkarni, Hannah Durham, Luke Glover, Osaid Ather, Leslie Cousens, Parmis Blomgran, Philip Ambery |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/12/e061476.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01) -
ADVERSE EFFECTS OF LONG-TERM CORTICOSTEROID THERAPY OF NEPHROTIC SYNDROME IN CHILDREN
by: T. L. Nastausheva, et al.
Published: (2017-08-01) -
Subdural Hematoma: An Adverse Event of Electroconvulsive Therapy—Case Report and Literature Review
by: Ranganath R. Kulkarni, et al.
Published: (2012-01-01) -
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
by: Chris Griffiths, et al.
Published: (2020-09-01) -
Trials special series - the collection, analysis and reporting of adverse events in randomised controlled trials
by: Rachel Phillips, et al.
Published: (2025-05-01)